Anti-carbonic anhydrase IX (CAIX) antibodies inhibit HIF-1 and topoisomerase-1 by targeting CAIX, rendering CAIX+ tumor cells more vulnerable to immune system destruction. Here, CA9 is linked to neoplasm.